메뉴 건너뛰기




Volumn 6, Issue 2, 2005, Pages 116-119

Fluocinolone acetonide ophthalmic - Bausch & Lomb: Fluocinolone acetonide envision TD implant
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

FLUOCINOLONE ACETONIDE; ORPHAN DRUG;

EID: 16844362809     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200506020-00007     Document Type: Article
Times cited : (24)

References (6)
  • 1
    • 16844381210 scopus 로고    scopus 로고
    • Results of 34-Week Data from Posterior Uveitis Clinical Trial Sponsored by Bausch & Lomb Presented at Retina Society
    • Bausch & Lomb Incorporated. Media Release: 22 Sep Available from URL:
    • Bausch & Lomb Incorporated. Results of 34-Week Data from Posterior Uveitis Clinical Trial Sponsored by Bausch & Lomb Presented at Retina Society. Media Release: 22 Sep 2003. Available from URL: http://www.bausch.com
    • (2003)
  • 2
    • 16844365631 scopus 로고    scopus 로고
    • Bausch and Lomb. 34-Week Data Analysis from Second Clinical Trial of Bausch & Lomb's Retisert Implant for Posterior Uveitis is Presented At The Retina Society Annual Meeting Media Release 04 Oct Available from URL:
    • Bausch and Lomb. 34-Week Data Analysis from Second Clinical Trial of Bausch & Lomb's Retisert Implant for Posterior Uveitis is Presented At The Retina Society Annual Meeting. Media Release: 04 Oct 2004. Available from URL: http://www.bausch.com
    • (2004)
  • 3
    • 16844373770 scopus 로고    scopus 로고
    • Bausch & Lomb Fourth-Quarter Sales Up 15 Percent, Comparable-Basis EPS Rise 38 Percent
    • Bausch & Lomb. Media Release: 29 Jan Available from URL:
    • Bausch & Lomb. Bausch & Lomb Fourth-Quarter Sales Up 15 Percent, Comparable-Basis EPS Rise 38 Percent. Media Release: 29 Jan 2004. Available from URL: http://www.bausch.com
    • (2004)
  • 4
    • 16844387355 scopus 로고    scopus 로고
    • Bausch & Lomb and Control Delivery Systems Announce Results of First Phase III Clinical Trial of Envision TD Ophthalmic Implant for Treatment of Diabetic Macular Edema
    • Bausch & Lomb. Media Release: 6 Jun Available from URL:
    • Bausch & Lomb. Bausch & Lomb and Control Delivery Systems Announce Results of First Phase III Clinical Trial of Envision TD Ophthalmic Implant for Treatment of Diabetic Macular Edema. Media Release: 6 Jun 2002. Available from URL: http://www.bausch.com
    • (2002)
  • 5
    • 16844369580 scopus 로고    scopus 로고
    • Bausch & Lomb. Data Analysis from Clinical Trials of Bausch & Lomb's Retisert Implant for Posterior Uveitis and Diabetic Macular Edema Presented at American Academy of Ophthalmology Media Release: 14 Nov Available from URL:
    • Bausch & Lomb. Data Analysis from Clinical Trials of Bausch & Lomb's Retisert Implant for Posterior Uveitis and Diabetic Macular Edema Presented at American Academy of Ophthalmology. Media Release: 14 Nov 2003. Available from URL: http://www.bausch.com
    • (2003)
  • 6
    • 16844373262 scopus 로고    scopus 로고
    • Bausch and Lomb. Bausch & Lomb: Analysis of Six-Month Trial of Fluocinolone Acetonide Implant in the Treatment of Diabetic Macular Edema Presented at Retina Congress 2002 Media Release: 30 Sep Available from URL
    • Bausch and Lomb. Bausch & Lomb: Analysis of Six-Month Trial of Fluocinolone Acetonide Implant in the Treatment of Diabetic Macular Edema Presented at Retina Congress 2002. Media Release: 30 Sep 2002, Available from URL http://www.bausch.com
    • (2002)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.